CN107353318A - The preparation method of 6 dehydrogenation nandrolone acetates - Google Patents
The preparation method of 6 dehydrogenation nandrolone acetates Download PDFInfo
- Publication number
- CN107353318A CN107353318A CN201710564057.8A CN201710564057A CN107353318A CN 107353318 A CN107353318 A CN 107353318A CN 201710564057 A CN201710564057 A CN 201710564057A CN 107353318 A CN107353318 A CN 107353318A
- Authority
- CN
- China
- Prior art keywords
- reaction
- preparation
- dehydrogenations
- nandrolone
- purity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
Abstract
Description
Claims (10)
- A kind of 1. preparation method of 6- dehydrogenations nandrolone acetate, it is characterised in that:In reaction vessel, by compound 3,5- female steroids Diene -3,17 β-diacetate is dissolved in the mixed liquor of DMF and water, and at -10 DEG C to -5 DEG C, magnetic force stirs maintenance system reaction temperature Mix, the NBS solution being dissolved in DMF is added dropwise, while maintenance reaction temperature after the completion of feeding intake, is warming up to 25 below 0 DEG C DEG C, detected and reacted with TLC, after question response is completed, put into a certain amount of sodium carbonate to system first, treat sodium carbonate in reaction solution In be completely dissolved after, then to system put into a certain amount of sodium bromide, after the completion of feeding intake, reaction system be warming up to 35-45 DEG C, Maintain this temperature to continue to react half an hour, after being gradually heating to 75-85 DEG C, maintain this temperature to continue to react, reaction stops after terminating Only heat, reaction system is cooled to 20-25 DEG C, stops stirring, the acetic acid that half volume is added to reaction system is water-soluble Liquid, after the completion of addition, stirring reaction system for a period of time, then adds the acetic acid aqueous solution of equivalent, continues stirring reaction 12h, after no longer solid is separated out, with filtered on buchner funnel product, the mixed liquor with 0 DEG C to 5 DEG C of isopropanol and purified water is clear Filter wash cake, pale yellow powder is obtained, desciccate to constant weight, produces 6- dehydrogenation nandrolone acetate net products.
- A kind of 2. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:3,5- female steroids two Mass ratio between the β of alkene-3,17-diacetate, DMF, water three is (15-20):(50-70):1, preferably 16:60:1.
- A kind of 3. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:NBS is dissolved in 3 In the DM F of times quality.
- A kind of 4. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:The matter of sodium carbonate Amount is the 5-10% of 3,5- estradienes -3,17 β-diacetate, preferably 5%.
- A kind of 5. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:The matter of sodium bromide Amount is the half of sodium carbonate.
- A kind of 6. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:Acetic acid aqueous solution Concentration be V acetic acid:V water=1:5, mixing time is half an hour after adding acetic acid solution for the first time.
- A kind of 7. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:In course of reaction Heating use oil bath heating, reaction vessel bottom is immersed in silicone oil, submergence be silicone oil highly be higher than reaction vessel in Reaction solution height.
- A kind of 8. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:Isopropyl alcohol and water Mass ratio be 2:3.
- A kind of 9. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:3,5- female steroids two The purity that the purity of alkene -3,17 β-diacetate is 98%, DMF is that 99.5%, NBS purity is 99%, and the purity of sodium carbonate is 99.8%, the purity of sodium bromide is 99%, and the purity of acetic acid is 99.5%, and the purity of isopropanol is 99.7%.
- A kind of 10. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:Magnetic agitation Device rotating speed is 500 turns/s.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710564057.8A CN107353318A (en) | 2017-07-12 | 2017-07-12 | The preparation method of 6 dehydrogenation nandrolone acetates |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710564057.8A CN107353318A (en) | 2017-07-12 | 2017-07-12 | The preparation method of 6 dehydrogenation nandrolone acetates |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107353318A true CN107353318A (en) | 2017-11-17 |
Family
ID=60293270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710564057.8A Pending CN107353318A (en) | 2017-07-12 | 2017-07-12 | The preparation method of 6 dehydrogenation nandrolone acetates |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107353318A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108047299A (en) * | 2017-12-29 | 2018-05-18 | 广西万德药业有限公司 | The preparation method of canrenone important intermediate |
CN114634542A (en) * | 2022-03-30 | 2022-06-17 | 湖北武当安泰药业有限公司 | Preparation method of dehydronandrolone acetate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104292285A (en) * | 2014-09-30 | 2015-01-21 | 湖北三晶生物科技有限公司 | Process for synthesizing high-content dehydronandrolon acetate |
WO2015181116A1 (en) * | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
-
2017
- 2017-07-12 CN CN201710564057.8A patent/CN107353318A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015181116A1 (en) * | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
CN104292285A (en) * | 2014-09-30 | 2015-01-21 | 湖北三晶生物科技有限公司 | Process for synthesizing high-content dehydronandrolon acetate |
Non-Patent Citations (1)
Title |
---|
饶志威: "《脱氢诺龙醋酸酯的合成工艺研究》", 《中国药物化学杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108047299A (en) * | 2017-12-29 | 2018-05-18 | 广西万德药业有限公司 | The preparation method of canrenone important intermediate |
CN108047299B (en) * | 2017-12-29 | 2021-11-09 | 广西万德药业有限公司 | Preparation method of important intermediate of canrenone |
CN114634542A (en) * | 2022-03-30 | 2022-06-17 | 湖北武当安泰药业有限公司 | Preparation method of dehydronandrolone acetate |
CN114634542B (en) * | 2022-03-30 | 2022-11-25 | 湖北武当安泰药业有限公司 | Preparation method of dehydronandrolone acetate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021258723A1 (en) | Method for synthesizing lithocholic acid with ba as raw material | |
US3562260A (en) | 2-carbonyl-estratrienes and method of their preparation | |
JPS5946299A (en) | 11 beta- and 2-substituted novel 19-norsteroids, manufacture, use as drug, composition and novel intermediates | |
CN104262442B (en) | The preparation method of Progesterone | |
CN109776644B (en) | Synthesis method of progesterone | |
CN106866766B (en) | The preparation method and preparation system of a kind of medroxyprogesterone acetate | |
WO2021012673A1 (en) | Method for preparing trenbolone acetate | |
CN107353318A (en) | The preparation method of 6 dehydrogenation nandrolone acetates | |
CN100422204C (en) | 7-keto deoxy epiandrosterone and its acetate synthesizing method | |
WO2021012671A1 (en) | Highly efficient preparation method for progesterone with low pollution | |
CN106831923B (en) | A kind of preparation method of chenodeoxycholic acid | |
CN109422642A (en) | Refining methd, the production method and equipment of pharmaceutical grade sodium benzoate of benzoic acid | |
CN101560237A (en) | 14beta-hydro6beta,7beta,15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21,17-carbolactone and synthesis method thereof | |
CN110204585A (en) | A kind of synthetic method of progesterone | |
CN109503691A (en) | A kind of synthetic method of 5 α-androstane -3,17- diketone | |
CN107188916A (en) | A kind of preparation method of 6 dehydrogenation nandrolone acetate | |
CN115466300A (en) | Cholic acid intermediate A7 and synthesis method thereof | |
CN107200762A (en) | The preparation method of the β diacetates of 3,5 estradiene 3,17 | |
CN109369760B (en) | Method for preparing dehydromethyltestosterone | |
CN104059118B (en) | The method that 4-alkene-3-ketone is 3 Alpha-hydroxy-5 β-hydrogen A/B cis-structure in stereo selectivity one step reduction steroid backbone | |
CN104788529B (en) | The preparation method of 5 α-chloro-androstane-6 β, 19-epoxy-3,17-diketone | |
CN109627275A (en) | A kind of bis- dehydrogenation -17a- hydroxyl progesterone product preparation methods of 1,6- | |
CN107011403B (en) | A kind of preparation method for improving cholesterol purity | |
Nussbaum et al. | Some substances derived from ruscogenin | |
Klimstra et al. | Anabolic agents. A-ring oxygenated androstane derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181205 Address after: 442700 Baiguoshu Lute No. 1, Shuidu Industrial Park, Danjiangkou Economic Development Zone, Shiyan City, Hubei Province Applicant after: Hubei Gongtong Biological Science & Technology Co., Ltd. Address before: 442700 Baiguoshu Lute No. 1, Shuidu Industrial Park, Danjiangkou Economic Development Zone, Shiyan City, Hubei Province Applicant before: Hubei Gongtong Biological Science & Technology Co., Ltd. Applicant before: Hubei Industry University |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190319 Address after: 441400 Gaokeng Group, Xiaohe Town, Yicheng City, Xiangfan City, Hubei Province Applicant after: Hubei Common Pharmaceutical Co., Ltd. Address before: 442700 Baiguoshu Lute No. 1, Shuidu Industrial Park, Danjiangkou Economic Development Zone, Shiyan City, Hubei Province Applicant before: Hubei Gongtong Biological Science & Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171117 |
|
RJ01 | Rejection of invention patent application after publication |